Medical Device News Magazine

MSA Safety Reports 1st Elastomeric Respirator Without Exhalation Valve Is Approved by NIOSH

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

November 25, 2020

MSA Safety today reported that its next-generation Advantage 290 LS Air-Purifying Respirator (APR) is the first of its kind — designed without an exhalation valve — to receive approval from the National Institute for Occupational Safety and Health (NIOSH).

MSA Safety notes an elastomeric half-mask device, the Advantage 290 LS Respirator covers a wearer’s nose and mouth and utilizes twin filters to provide respiratory protection.

The U.S. Centers for Disease Control and Prevention (CDC) advises that NIOSH-approved respirators, including elastomeric half-mask respirators (EHMRs), are appropriate for use against SARS-CoV-2 in healthcare settings.  This established class of respirator can play a critical role in the nation’s response to COVID-19 and, importantly, bolster future readiness for similar microbial viruses and other emergencies.

In response to the global shortage of personal protective equipment (PPE), MSA has been working throughout the year with healthcare professionals to identify the respiratory protection needs of those on the front line of the pandemic.  Some applications within healthcare require a sterile environment, and one critical component to ensuring a sterile environment is source control. The Advantage 290 Respirator is the first EHMR to function without an exhalation valve, making it a new respiratory protection option that provides both personal protection and source control.  In addition, the new respirator gives healthcare facilities greater optionality and flexibility in developing their respiratory protection programs in accordance with Occupational Safety and Health Administration standards.

“Given the reusable design and nature of elastomeric respirators, there are many benefits of deploying a respiratory protection program that incorporates EHMRs, including cost-efficiency, reduced space requirements for PPE warehousing, and fewer concerns associated with PPE insecurities during a pandemic,” said Greg Martin, MSA Vice President of Product Strategy and Development.

Mr. Martin added that EHMRs also help mitigate concerns about product expiration while conferring additional benefits, like environmental sustainability, through extended use and reuse capability. “With the Advantage 290 model, our team went a step further and developed a respirator that has the potential to be an even more appealing option – today and down the road – for healthcare systems everywhere as they assess plans for the future and their own pandemic preparedness,” he said.

The Advantage 290 Respirator, which will be available for preorder in December 2020, will be produced at MSA Safety’s subsidiary operation in Jacksonville, N.C.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”